Quest Diagnostics Incorporated (dgx)
DGX Estimates
Public analyst price targets and consensus snapshot for Quest Diagnostics Incorporated. Deeper estimate history and models are available in Vest Terminal.
| Last price | $233.00 |
| Analyst mean target | $247.73 |
| Analyst high target | $265.00 |
| Analyst low target | $204.00 |
| Upside vs mean target | 6.3% |
| Consensus recommendation | Buy |
| Number of analysts | 15 |
| Forward P/E | 19.32 |
Start Free — open DGX in Vest Terminal
Access live data, filings, ownership, and analysis for Quest Diagnostics Incorporated.
Quest Diagnostics Incorporated FAQ
What does Quest Diagnostics Incorporated (DGX) do?
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic informati…
What is DGX's P/E ratio?
Quest Diagnostics Incorporated has a trailing P/E of 25.77× based on publicly available market data.
Does DGX pay a dividend?
Indicated dividend yield: 1.5%. Confirm ex-dates and payout history in Vest Terminal.
What sector is DGX in?
Quest Diagnostics Incorporated is classified in Healthcare (Diagnostics & Research) on NYQ.
What is DGX's market capitalization?
Approximate market cap: $25.72B.
What are the main risks for DGX?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of DGX?
Potential positives include revenue growth of 10.2% year-over-year, earnings growth of 15.0% year-over-year.
Where can I get analyst estimates for DGX?
Public analyst price targets and consensus for Quest Diagnostics Incorporated are on the free /stocks/dgx/estimates page. Deeper estimate history and models are available in Vest Terminal.